Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Weighing the Potential Benefits and Risks of a Transaction

Skip to the end of the Expertise Menu

Weighing the Potential Benefits and Risks of a Transaction

By Steve Grassa

The dermatology sector has experienced an unprecedented amount of consolidation activity in recent years, primarily driven by private equity investment in the space. The recent wave of private investment began in 2011 when Advanced Dermatology & Cosmetic Surgery completed a recapitalization with private equity firm, Audax Group. Since that initial investment, over two dozen additional private equity groups have invested into the specialty, creating a competitive environment for acquisitions with attractive valuation structures and robust transaction volume.  As a result, approximately 10% of dermatologists in the country practice medicine with an organization backed by private equity dollars.

To access the full article which was featured in the December/January issue of Executive Decisions in Dermatology , download the PDF.

Learn more about ADAM here.